UK government plans to spend £100bn on expanding Covid-19 testing to 10 million a day


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ UK government plans to spend £100bn on expanding Covid-19 testing to 10 million a day
The Moonshot program will be rolled out immediately among general public

The UK government has drawn up plans to carry out up to 10 million covid-19 tests a day by early next year as part of a huge £100bn expansion of its national testing programme, documents seen by The BMJ reveal.

A briefing memo sent to the first minister and cabinet secretaries in Scotland, seen by The BMJ, reveals the UK-wide Moonshot programme is expected to “cost over £100 billion to deliver.” If achieved, the programme would allow testing of the entire UK population per week.

Under the plan the government will roll out testing in workplaces, entertainment venues, and football stadiums, and at GP surgeries, pharmacies, schools, and other local sites to improve access. It will also roll out digital immunity passports to allow people who test negative to return to workplaces, travel, and participate in other activities.

The leaked documents reveal a heavy reliance on the private sector to achieve the mass testing and details ‘letters of comfort’ which have already been signed with companies to reach 3 million tests per day by December. Firms named are GSK for supplying tests, AstraZeneca for lab capacity and Serco and G4s for logistics and warehousing.

But critics have already rounded on the plans as “devoid of any contribution from scientists, clinicians, public health, test and screening experts,” and “disregarding the enormous problems with the existing testing and tracing programmes.”

Commenting on the leaked plans, Martin McKee, professor of European public health at the London School of Hygiene and Tropical Medicine said they bore the hallmark of a government “whose ambition far exceeds its ability to deliver.”

Devi Sridhar, Professor and Chair of Global Public Health at the University of Edinburgh, said she was glad the government is moving in the direction of mass testing but is concerned about the reliance on the private sector to deliver this.

While Jon Deeks, professor of biostatistics at the University of Birmingham and leader of the Cochrane Collaboration’s covid-19 test evaluation activities warned that mass testing could lead to “substantial economic harm and massive need for further testing.”

Tags : #MoonshotProgramUK #AstraZeneca #BMJ #GSK #Serco #G4 #UKgoesformasstesting #LondonSchoolofHygiene #UniversityOfBirmingham #LatestUKCovidNewsSep12

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026